It's final: The AP reports enough claimants have agreed, and Merck will settle with thousands of women over allegations about the safety of NuvaRing. The pharma giant will shell out $100 million, but (according to earlier reports) admitted no fault and says there's "substantial" evidence the contraceptive is safe.